Phase II trial of neoadjuvant nivolumab with cisplatin and gemcitabine in muscle-invasive bladder cancer patients undergoing radical cystectomy.

被引：1
|
作者：
Gupta, Shilpa
Agarwal, Neeraj
Konety, Badrinath R.
Weight, Christopher J.
Thyagarajan, Bharat
Murugan, Paari J.
Koopmeiners, Joseph S.
Sonpavde, Guru
机构：
[1] Univ Minnesota Mason Canc Ctr, Minneapolis, MN USA
[2] Huntsman Canc Hosp, Salt Lake City, UT USA
[3] Univ Minnesota, Minneapolis, MN USA
[4] Dana Farber Canc Inst, Boston, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.TPS528
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS528
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant pembrolizumab for cisplatin-ineligible muscle-invasive bladder cancer prior to radical cystectomy.
    Rose, Kyle M.
    Bandini, Marco
    Huelster, Heather L.
    Basile, Giuseppe
    Naidu, Shreyas U.
    Spiess, Philippe E.
    Necchi, Andrea
    Li, Roger
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [2] Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomy
    Pichler, Renate
    Fritz, Josef
    Mari, Andrea
    Cadenar, Anna
    von Deimling, Markus
    Marcq, Gautier
    del Giudice, Francesco
    Leonardo, Costantino
    Bologna, Eugenio
    Mori, Keiichiro
    Tahbaz, Rana
    De Santis, Maria
    Klatte, Tobias
    Erber, Barbara
    Lackner, Felizian
    Kronbichler, Andreas
    Seeber, Andreas
    Fisch, Margit
    Moschini, Marco
    Pradere, Benjamin
    Mertens, Laura S.
    [J]. ONCOLOGIST, 2024,
  • [3] PHASE 2 TRIAL OF NEOADJUVANT GEMCITABINE AND CARBOPLATIN FOR MUSCLE-INVASIVE BLADDER CANCER FOLLOWED BY RADICAL CYSTECTOMY
    Koie, Takuya
    Okamoto, Teppei
    Imanishi, Kengo
    Sugiyama, Naoki
    Kudoh, Shigemasa
    Mori, Kazuyuki
    Tachiwada, Tokushi
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Kamimura, Noritaka
    Ohyama, Chikara
    Suzuki, Yuichiro
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E657 - E657
  • [4] A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: clinical and pathological results
    Pruthi, Raj S.
    Nielsen, Matthew
    Heathcote, Samuel
    Wallen, Eric M.
    Rathmell, W. Kim
    Godley, Paul
    Whang, Young
    Fielding, Julia
    Schultz, Heather
    Grigson, Gayle
    Smith, Angela
    Kim, William
    O'Donnell, Peter H.
    [J]. BJU INTERNATIONAL, 2010, 106 (03) : 349 - 356
  • [5] Neoadjuvant nivolumab, gemcitabine and cisplatin in muscle-invasive bladder cancer: Study update
    Gupta, Shilpa
    Weight, Christopher J.
    Agarwal, Neeraj
    Gupta, Sumati
    Konety, Badrinath
    Gibb, Ewan
    Davicioni, Elai
    Thyagarajan, Bharat
    Sonpavde, Guru
    [J]. CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [6] Phase II trial of neoadjuvant cisplatin, gemcitabine, and bevacizumab followed by radical cystectomy (RC) in patients with muscle-invasive transitional cell carcinoma (TCC) of the bladder
    Chaudhary, U. B.
    Golshayan, A. R.
    Brisendine, A.
    Kraft, A. S.
    Clarke, H.
    Keane, T. E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [7] A phase II study of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: Preliminary results
    Kim, W. Y.
    Grigson, G. I.
    Wallen, E. M.
    Pruthi, R. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] A Phase II Trial of Neoadjuvant Erlotinib in Patients With Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy: Clinical and Pathological Results Editorial Comment
    Wood, David P.
    [J]. JOURNAL OF UROLOGY, 2011, 185 (03): : 811 - 812
  • [9] A prospective phase II trial of neoadjuvant nivolumab plus gemcitabine/cisplatin chemotherapy in muscle-invasive urothelial carcinoma of bladder.
    Kim, Hongsik
    Kim, Ryul
    Hong, Joohyun
    Kwon, Ghee Young
    Kim, Chan Kyo
    Park, Won
    Song, Wan
    Sung, Hyun Hwan
    Jeong, Byong Chang
    Hong, Jung Yong
    Park, Se Hoon
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [10] A phase II study of neoadjuvant erlotinib (Tarceva) in patients with muscle-invasive bladder cancer undergoing radical cystectomy: Preliminary results
    Smith, Angela
    Coward, Matthew
    Kim, William
    Nielsen, Matthew
    Wallen, Eric
    Pruthi, Raj S.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 209 (03) : S129 - S129
12345